Nancy Cox, who for decades was a global leader in influenza research, has died. Cox headed the influenza team at the Centers ...

Torie Bosch: Whether it’s Ambien or Wegovy, ivermectin or fluoride, every drug in your medicine cabinet or advertised on TV ...

A Utah pilot to renew prescriptions using a bot faced backlash from the state's medical board, which called for an immediate ...

Trump's embrace of psychedelics and cannabis is shaking up the GOP’s relationship with mind-altering substances.

What did Eli Lilly see in a struggling biotech startup that made the pharma giant want to pay billions for it? Bryan Roberts ...

BioAge is making its way into the race among drug companies to target inflammation as a way to treat chronic conditions.

The problematic use of guest editors was spotlighted last week when a genetics journal retracted nearly an entire special ...

The Swiss drugmaker Roche presented the latest data for its experimental multiple sclerosis drug, setting the stage for the ...

WASHINGTON — President Trump heralded a drug pricing agreement with Regeneron on Thursday, closing the last of 17 deals ...

The Trump administration, in a stark departure from the "Just Say No" era, is funding psychedelics research and rescheduling ...

This week on "The Readout LOUD": a CAR-T biotech's dramatic turnaround, and drugmakers' tactics to drive more scripts. Listen ...